Autotelicbio
Clinical trials sponsored by Autotelicbio, explained in plain language.
-
New drug ATB-320 enters first human safety trial for Hard-to-Treat cancers
Disease control Not yet recruitingThis early-stage trial tests the safety of a new drug called ATB-320 in 24 adults with advanced solid tumors that have spread or stopped responding to standard treatments. The main goal is to find the highest safe dose and identify any side effects. Participants will receive the …
Phase: PHASE1 • Sponsor: Autotelicbio • Aim: Disease control
Last updated May 17, 2026 03:15 UTC
-
New combo pill for diabetes and hypertension tested in healthy adults
Knowledge-focused Not yet recruitingThis early-stage study tests whether a new single tablet (ATB-U101) that combines two common drugs for type 2 diabetes and high blood pressure works the same as taking the two drugs separately. About 36 healthy Caucasian adults will receive each treatment once, with blood samples…
Phase: PHASE1 • Sponsor: Autotelicbio • Aim: Knowledge-focused
Last updated May 17, 2026 03:14 UTC